S
CAPR icon

SignatureFD’s Capricor Therapeutics CAPR Stock Holding History

SignatureFD’s Portfolio CAPR Stock Details CAPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-82
Closed -$778 – 3287
2025
Q1 		$778 Buy
+82
New +$1.14K ﹤0.01% 3097
2024
Q4 		– Sell
-393
Closed -$5.98K – 3324
2024
Q3 		$5.98K Hold
393
– – ﹤0.01% 2518
2024
Q2 		$1.88K Buy
+393
New +$2.19K ﹤0.01% 2770

Other funds holding CAPR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PC
Pier Capital Stamford, Connecticut $606M AUM 63.41% 1-Year Est. Return
BDF
Black Diamond Financial Towson, Maryland $916M AUM 15.95% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

SignatureFD's CAPR Position: Q2 2025 in Review

SignatureFD sold out of Capricor Therapeutics (CAPR) in Q2 2025, closing a stake of 82 shares — an estimated $778 sold.

SignatureFD first reported a position in CAPR in Q2 2024 and held it in 3 quarters. The position peaked at $5.98K in Q3 2024. 107 funds tracked by Wall St. Rank hold CAPR as of Q2 2025.

  • SignatureFD reported no remaining Capricor Therapeutics position as of Q2 2025 after selling out during the quarter.
  • SignatureFD sold 82 Capricor Therapeutics shares in Q2 2025, an estimated $778.
  • SignatureFD first reported a position in Capricor Therapeutics in Q2 2024 and held it in 3 quarters.
  • SignatureFD's Capricor Therapeutics position peaked at $5.98K in Q3 2024.
  • 107 funds tracked by Wall St. Rank held Capricor Therapeutics as of Q2 2025.

Based on SignatureFD's 13F filing for Q2 2025, filed 16 Jul 2025.